Journey Medical Corporation DERM Stock
Journey Medical Corporation Price Chart
Journey Medical Corporation DERM Financial and Trading Overview
| Journey Medical Corporation stock price | 5.97 USD |
| Previous Close | 2.08 USD |
| Open | 2.02 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 900 |
| Day's Range | 2.02 - 2.38 USD |
| 52 Week Range | 1.02 - 4.36 USD |
| Volume | 129.75K USD |
| Avg. Volume | 86.26K USD |
| Market Cap | 40.06M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.72 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.67 USD |
DERM Valuation Measures
| Enterprise Value | 47.11M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.9464285 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.64006877 |
| Price/Book (mrq) | 5.261905 |
| Enterprise Value/Revenue | 0.753 |
| Enterprise Value/EBITDA | -1.532 |
Trading Information
Journey Medical Corporation Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -24.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.36 USD |
| 52 Week Low | 1.02 USD |
| 50-Day Moving Average | 1.54 USD |
| 200-Day Moving Average | 1.95 USD |
DERM Share Statistics
| Avg. Volume (3 month) | 86.26K USD |
| Avg. Daily Volume (10-Days) | 406.33K USD |
| Shares Outstanding | 12.13M |
| Float | 6.94M |
| Short Ratio | 0.78 |
| % Held by Insiders | 54.64% |
| % Held by Institutions | 15.40% |
| Shares Short | 36.24K |
| Short % of Float | 0.41% |
| Short % of Shares Outstanding | 0.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -61.33% |
| Operating Margin (ttm) | -56.067% |
| Gross Margin | 54.58% |
| EBITDA Margin | -49.15% |
Management Effectiveness
| Return on Assets (ttm) | -20.23% |
| Return on Equity (ttm) | -156.90% |
Income Statement
| Revenue (ttm) | 62.59M USD |
| Revenue Per Share (ttm) | 3.55 USD |
| Quarterly Revenue Growth (yoy) | -47.59% |
| Gross Profit (ttm) | 42.89M USD |
| EBITDA | -30761000 USD |
| Net Income Avi to Common (ttm) | -38386000 USD |
| Diluted EPS (ttm) | -2.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.35M USD |
| Total Cash Per Share (mrq) | 0.96 USD |
| Total Debt (mrq) | 26.76M USD |
| Total Debt/Equity (mrq) | 357.15 USD |
| Current Ratio (mrq) | 0.79 |
| Book Value Per Share (mrq) | 0.42 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15374000 USD |
| Levered Free Cash Flow (ttm) | -10742250 USD |
Profile of Journey Medical Corporation
| Country | United States |
| State | AZ |
| City | Scottsdale |
| Address | 9237 East Via de Ventura Boulevard |
| ZIP | 85258 |
| Phone | 480 434 6670 |
| Website | https://journeymedicalcorp.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Zilxi, a topical minocycline treatment for inflammatory lesions; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.
Q&A For Journey Medical Corporation Stock
What is a current DERM stock price?
Journey Medical Corporation DERM stock price today per share is 5.97 USD.
How to purchase Journey Medical Corporation stock?
You can buy DERM shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Journey Medical Corporation?
The stock symbol or ticker of Journey Medical Corporation is DERM.
Which industry does the Journey Medical Corporation company belong to?
The Journey Medical Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does Journey Medical Corporation have in circulation?
The max supply of Journey Medical Corporation shares is 23.1M.
What is Journey Medical Corporation Price to Earnings Ratio (PE Ratio)?
Journey Medical Corporation PE Ratio is now.
What was Journey Medical Corporation earnings per share over the trailing 12 months (TTM)?
Journey Medical Corporation EPS is -0.72 USD over the trailing 12 months.
Which sector does the Journey Medical Corporation company belong to?
The Journey Medical Corporation sector is Healthcare.
Journey Medical Corporation DERM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17449.89 USD — |
+0.87
|
6.97B USD — | 17149.36 USD — | 17506.58 USD — | — - | 6.97B USD — |
| NASDAQ Composite Total Return I XCMP | 21356.17 USD — |
+0.87
|
— — | 20988.36 USD — | 21425.55 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 929.13 USD — |
-1.85
|
— — | 925.14 USD — | 947.12 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4471.71 USD — |
-2.63
|
— — | 4460.14 USD — | 4595.5 USD — | — - | — — |
- {{ link.label }} {{link}}